Johnson & Johnson said it planned to terminate the deal with contract manufacturer Emergent BioSolutions, as both companies accused each other of breaching the agreement.
J&J Plans to End Covid-19 Vaccine Deal With Emergent BioSolutions
Wall Street Journal - 7 Jun 2022 03:41
Johnson & Johnson said it planned to terminate the deal with contract manufacturer Emergent BioSolutions, as both companies accused each other of breaching the agreement.
Share this Article
Recommended